Minerva Neurosciences, Inc.
General ticker "NERV" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $15.9M (TTM average)
Minerva Neurosciences, Inc. follows the US Stock Market performance with the rate: 36.7%.
Estimated limits based on current volatility of 6.7%: low 3.24$, high 3.71$
Factors to consider:
- Total employees count: 8 as of 2024
- Top business risk factors: Operational and conduct risks, Product side effects, Sales and marketing challenges, Strategic risks and growth management, Third-party risks
- Price in estimated range
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [1.22$, 4.02$]
- 2025-12-31 to 2026-12-31 estimated range: [1.01$, 3.36$]
Financial Metrics affecting the NERV estimates:
- Positive: with PPE of 11.6 at the end of fiscal year the price was very low
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -117.23 <= 0.33
- Negative: negative Industry operating cash flow (median)
- Positive: 1.87 < Return on assets ratio (scaled to [-100,100]) of 3.73
- Positive: Industry inventory ratio change (median), % of 0 <= 0
- Positive: Investing cash flow per share per price, % of 0 > -0.66
- Negative: Shareholder equity ratio, % of -69.17 <= 18.93
Short-term NERV quotes
Long-term NERV plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $25.23MM | $23.12MM | $21.85MM |
| Operating Income | $-25.23MM | $-23.12MM | $-21.85MM |
| Non-Operating Income | $-6.88MM | $-6.89MM | $23.29MM |
| Interest Expense | $7.41MM | $8.28MM | $4.56MM |
| R&D Expense | $14.65MM | $12.71MM | $11.90MM |
| Income(Loss) | $-32.11MM | $-30.01MM | $1.44MM |
| Profit(Loss)* | $-32.11MM | $-30.01MM | $1.44MM |
| Stockholders Equity | $-20.02MM | $-28.46MM | $-25.69MM |
| Assets | $55.09MM | $56.90MM | $37.14MM |
| Operating Cash Flow | $-24.65MM | $-14.78MM | $-19.55MM |
| Capital expenditure | $0.02MM | $0.00MM | $0.00MM |
| Investing Cash Flow | $-0.02MM | $0.00MM | $0.00MM |
| Financing Cash Flow | $-0.00MM | $19.60MM | $0.00MM |
| Earnings Per Share** | $-6.01 | $-4.61 | $0.19 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.